Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Holds Special Meeting for Shareholder Vote on Acquisition by Hologic

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Friday it will be holding a special shareholder meeting on July 31 during which shareholders will vote on the proposed $3.7 billion acquisition of the company by Hologic.

Hologic's bid for Gen-Probe, under which it would pay $82.75 per share of Gen-Probe's stock, was announced in April. Earlier this month, the deal cleared antitrust review by US regulators.

The special meeting will be held at Gen-Probe's headquarters in San Diego. Shareholders of Gen-Probe stock as of the end of the business day on June 29 are eligible to vote on the deal.

Planning efforts to integrate Gen-Probe into Hologic have already begun, and in June, a Hologic official said that once the deal is completed Gen-Probe would become the "hub" of Hologic's diagnostics business.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.